Rhenium-SCT®
![non-invasive](/fileadmin/user_upload/icons/non-invasive.png)
![painless](/fileadmin/user_upload/icons/painless.png)
![aesthetic](/fileadmin/user_upload/icons/aesthetic.png)
The Rhenium-SCT (Skin Cancer Therapy) is a specialized state-of-the-art brachytherapy utilizing the radioisotope Rhenium-188, a beta-emitter which in this case is used for the treatment of basal and squamous cell carcinomas of the skin.
![comparison of ears after treatment](/fileadmin/user_upload/ears.jpg)
![example of Re-188 compound applied to forehead](/fileadmin/user_upload/treatment-shaded.jpg)
188W/188Re Generator
Production of high-energy beta emitting 188Re
![Wolfram Rhenium Generator](/fileadmin/user_upload/Generator_OBG.png)
Various sizes available
up to 150GBq (4Ci) 188W
High activity concentration
up to 9GBq/ml
Variable elution volume
Elution volume of 5-14 ml (partial elution for small volumes)
Low breakthrough
188W < 0.01 % in relation to 188Re at calibration time
Who we are
OncoBeta GmbH is a pioneer in the radioisotope sector, presently offering an innovative Skin Cancer Therapy targeting non-melanoma skin cancers and producing Tungsten (Wolfram)-188/Rhenium-188 (W/Re-188) Generators for commercial use.